Circulating tumor DNA (ctDNA) to detect neuroendocrine prostate cancer genomic and DNA methylation changes

被引：0

作者：

Beltran, Himisha

Romanel, Alessandro

Conteduca, Vincenza

Casiraghi, Nicola

Sigouros, Michael

Franceschini, Gian Marco

Fedrizzi, Tarcisio

Ku, Sheng-Yu

Alonso, Alicia

Mosquera, Juan Miguel

Dann, Emma

Sboner, Andrea

Xiang, Jenny

Elemento, Olivier

Nanus, David M.

Tagawa, Scott T.

Benelli, Matteo

Demichelis, Francesca

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Univ Trento, Trento, Italy

[3] Dana Farber Canc Inst, Boston, MA 02115 USA

[4] Weill Cornell Med, Div Med Oncol, Dept Med, New York, NY USA

[5] Weill Cornell Med, New York, NY USA

[6] Weill Cornell Med Coll, Englander Inst Precis Med, Dept Pathol & Lab Med, New York, NY USA

[7] New York Presbyterian Hosp, New York, NY USA

[8] Weill Cornell Med Coll, New York, NY USA

[9] Weill Cornell Med Coll, Inst Computat Biomed, Englander Inst Precis Med, Dept Physiol & Biophys, New York, NY USA

[10] Sandra & Edward Meyer Canc Ctr, New York, NY USA

[11] Univ Trento, Dept Cellular Computat & Integrat Biol, Trento, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期

基金：

美国国家卫生研究院;

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 50 条

[1] Genomic profiling of metastatic prostate cancer through analysis of circulating tumor DNA (ctDNA).
Gourdin, Theodore Stewart
Lilly, Michael B.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
[2] Analysis of genomic alterations in matched circulating tumor cell DNA (CTC DNA) and plasma tumor DNA (ctDNA) in men with metastatic castration resistant prostate cancer (mCRPC).
Gupta, Santosh
Hovelson, Daniel H.
Tomlins, Scott A.
Kemeny, Gabor
Liu, Chia-Jen
George, Daniel J.
Rothwell, Colin
Anand, Monika
Nanus, David M.
Giannakakou, Paraskevi
Gregory, Simon
Armstrong, Andrew J.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[3] Whole exome sequencing (WES) of circulating tumor DNA (ctDNA) in patients with neuroendocrine prostate cancer (NEPC) informs tumor heterogeneity.
Beltran, Himisha
Romanel, Alessandro
Casiraghi, Nicola
Sigouros, Michael
Benelli, Matteo
Xiang, Jenny
Demichelis, Francesca
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[4] Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in advanced prostate cancer (aPC) over treatment and time.
Stenehjem, David D.
Hahn, Andrew W.
Nussenzveig, Roberto
Carroll, Emma
Gill, David Michael
Bailey, Erin B.
Batten, Julia Anne
Maughan, Benjamin Louis
Agarwal, Neeraj
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[5] Bridging the Gaps between Circulating Tumor Cells and DNA Methylation in Prostate Cancer
Flores, Bianca C. T.
Correia, Margareta P.
Rodriguez, Jose G.
Henrique, Rui
Jeronimo, Carmen
CANCERS, 2021, 13 (16)
[6] Landscape of circulating tumor DNA (ctDNA) in metastatic breast cancer
Davis, Andrew A.
Jacob, Saya
Gerratana, Lorenzo
Shah, Ami N.
Wehbe, Firas
Katam, Neelima
Zhang, Qiang
Flaum, Lisa
Siziopikou, Kalliopi
Platanias, Leonidas C.
Gradishar, William J.
Behdad, Amir
Cristofanilli, Massimo
CANCER RESEARCH, 2020, 80 (04)
[7] Prognostic value of circulating tumor DNA (ctDNA) in ovarian cancer
Heo, J.
Kim, Y-N.
Lee, J-Y.
Lee, S-T.
Shin, S.
Lee, K.
Lee, Y. J.
Kim, S. W.
Choi, J. R.
Kim, S.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S815 - S815
[8] Circulating tumor DNA (ctDNA) in precision oncology of ovarian cancer
Oikkonen, Jaana
Hautaniemi, Sampsa
PHARMACOGENOMICS, 2019, 20 (18) : 1251 - 1253
[9] Circulating tumor DNA (ctDNA) in the era of personalized cancer therapy
Khatami F.
Tavangar S.M.
Journal of Diabetes & Metabolic Disorders, 2018, 17 (1) : 19 - 30
[10] Characterizing changes in tumor mutational burden (TMB) by serial circulating tumor DNA (ctDNA) testing in patients with advanced prostate cancer (aPC).
Childs, Daniel S.
Kwon, Eugene D.
Ahmed, Mohamed E.
Mahmoud, Ahmed
Pessoa, Rodrigo Rodrigues
Nabavizadeh, Reza
Tsai, Jill
Drusbosky, Leylah
Bucheit, Leslie
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41

← 1 2 3 4 5 →